SCHEMBL5686383

SCHEMBL5686383

NC(=O)c1c(Oc2ccccc2C(F)(F)F)nc(N)nc1-c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
BTK Q06187 1/20 0.41
RORC P51449 2/20 0.41
KDM4E B2RXH2 2/20 0.39
ALDH1A1 P00352 2/20 0.39
HPGD P15428 2/20 0.39
ADORA2A P29274 4/20 0.39
ADORA1 P30542 2/20 0.39
LMNA P02545 1/20 0.39
TSHR P16473 1/20 0.39
PTPN1 P18031 2/20 0.38
MEN1 O00255 1/20 0.38
GAA P10253 1/20 0.38
KMT2A Q03164 1/20 0.38
MRGPRX1 Q96LB2 1/20 0.37
P2RY1 P47900 2/20 0.37
SCN9A Q15858 2/20 0.36
TTR P02766 1/20 0.36
POLB P06746 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4557970 0.82 TSHR (0.46) RORCTSHRPTPN1
SCHEMBL4559145 0.80 ADORA2A (0.56) BTKADORA2AADORA1MEN1GAA
SCHEMBL5686147 0.78 MGMT (0.45) KDM4EALDH1A1ADORA2AADORA1
SCHEMBL5689008 0.78 LMNA (0.43) KDM4EALDH1A1HPGDADORA2AADORA1
SCHEMBL4559639 0.78 ADORA2A (0.39) KDM4EALDH1A1ADORA2AADORA1MEN1
SCHEMBL4559176 0.75 SIRT2 (0.45) BTKKDM4EALDH1A1ADORA2AADORA1
SCHEMBL5686125 0.71 PARP10 (0.50) BTKADORA2AGAA
SCHEMBL16465331 0.71 GAA (0.45) KDM4EALDH1A1ADORA2AADORA1MEN1
SCHEMBL12495739 0.69 RORC (0.47) RORCKDM4EALDH1A1MEN1GAA
SCHEMBL4559387 0.68 LMNA (0.45) BTKALDH1A1ADORA2ALMNASCN9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1648464-A1 2-AMINO-4-HYDROXY-5-PYRIMIDINCARBOXAMID DERIVATIVES AND RELATED COMPOUNDS AS T-CELL ACTIVATION INHIBITORS FOR THE TREATMENT OF INFLAMMATIONS AMGEN INC. (US) 2006-04-26 EP disclosed
WO-2005009443-A1 2-AMINO-4-HYDROXY-5-PYRIMIDINECARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS INHIBITORS OF T CELL ACTIVATION FOR THE TREATMENT OF INFLAMMATORY DISEASES AMGEN INC. (US) 2005-02-03 WO disclosed